2018/2108(INI) Implementation of the Cross-border Healthcare Directive
Lead committee dossier:
Progress: Procedure completed
| Role | Committee | Rapporteur | Shadows |
|---|---|---|---|
| Lead | ENVI |
BELET Ivo ( PPE)
|
WÖLKEN Tiemo ( S&D),
KRUPA Urszula ( ECR),
RIES Frédérique ( ALDE),
PEDICINI Piernicola ( EFDD),
MÉLIN Joëlle ( ENF)
|
| Committee Opinion | IMCO |
GRAPINI Maria ( S&D)
|
Jasenko SELIMOVIC ( ALDE),
Richard SULÍK ( ECR)
|
| Committee Opinion | EMPL |
Lead committee dossier:
Legal Basis:
RoP 54
Legal Basis:
RoP 54Subjects
Events
2019/07/17
EC - Commission response to text adopted in plenary
Documents
2019/02/12
EP - Results of vote in Parliament
Documents
2019/02/12
EP - Debate in Parliament
Documents
2019/02/12
EP - Decision by Parliament
Details
The European Parliament adopted by 512 votes to 32, with 62 abstentions, a resolution on the implementation of the Cross-Border Healthcare Directive.
Parliament noted the benefits of the Directive in clarifying the rules on cross-border healthcare and in ensuring access to safe and high-quality cross-border healthcare in the Union, as well as for achieving patient mobility in accordance with the case law of the Court of Justice. It expressed disappointment, however, that a significant number of Member States have not effectively implemented the requirements for guaranteeing patients’ rights, urging Member States to transpose the Directive correctly in order to ensure high-quality and accessible cross-border healthcare for patients. Parliament recognised that specific improvements could be made with regard to access to prescribed medicines and continuity of treatment. It also called on the Commission to explore the possibility of expanding the scope of the Directive to include vaccination programmes, since the Directive does not cover these.
The Commission was invited to proceed with its triennial evaluation reports on the operation of the Directive and to factor patient quality of life and care outcomes into its evaluation of the cost-efficiency of the implementation of the Directive, and establish guidelines on implementation.
Funding
Members recalled that while the financing of cross-border healthcare is the responsibility of Member States, the Commission, through its health programmes, supported the cooperation provided for by the Directive.
Concerned about the proposed reduction in funding for the health programme, they called for the programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027).
Patient mobility
Parliament considered that the reasons for low patient mobility are fourfold:
- some Member States were quite late implementing the Directive;
- citizens’ awareness about their general rights to reimbursement is extremely low;
- certain barriers limiting cross-border healthcare have been erected by some Member States;
- information on patients seeking healthcare in another Member State on the basis of the Directive is missing or incomplete.
The Commission and Member States were asked to work together to assess, realign and simplify reimbursement procedures for patients receiving cross-border care, including by clarifying the reimbursement of follow-up care and procedures, and to set up coordinating one-stop-shop front offices at the relevant healthcare insurers. Parliament urged the Member States to notify the Commission of any decision to introduce limitations regarding reimbursement of costs, giving their reasons for doing so.
Border regions
The resolution encouraged Member States and border regions to deepen cross-border healthcare cooperation, in an efficient and financially sustainable manner, including by providing accessible, sufficient and understandable information, in order to secure the best possible care for patients.
Information for patients
Parliament called on the Commission and the Member States to invest further in the development and promotion of accessible and clearly visible National Contact Points (NCPs) and eHealth platforms for patients, which should provide user-friendly, digitally accessible and barrier-free information for patients and health professionals in multiple languages.
Rare diseases, rare cancers and European Reference Networks (ERNs)
Parliament stressed the importance of EU-wide cooperation in ensuring the efficient pooling of knowledge, information and resources to tackle rare and chronic diseases, including rare cancers, effectively across the EU. It encouraged the Commission, in that regard, to support the setting up of specialised centres for rare diseases in the EU, which should be fully integrated into the ERNs. It also recommended building on the steps already taken to increase public awareness and understanding of rare diseases and rare cancers and to increase funding for R&D.
Mutual recognition of (e-)prescriptions
Parliament called on Member States and their respective health authorities to address the legal and practical issues that are hindering the mutual recognition of medical prescriptions across the EU. It also called on the Commission to take steps to ensure that prescriptions issued by ERN-linked centres of expertise are accepted for reimbursement in all Member States.
EHealth
Members acknowledged that eHealth can help to ensure that health systems are sustainable, by reducing certain costs, and can be an important part of the EU’s response to current healthcare challenges. They welcomed the creation of the EU-wide eHealth Digital Service Infrastructure, which will foster the cross-border exchange of health data, specifically e-prescriptions and patient summaries. They called on the Commission to address the digital health needs in the Member States as a matter of priority.
Brexit
The Commission was asked to negotiate a solid agreement with post-Brexit UK on health, devoting specific attention to cross-border rights for patients and the functioning of the ERNs.
Documents
2019/02/12
EP - End of procedure in Parliament
2019/01/29
EP - Committee report tabled for plenary
Details
The Committee on the Environment, Public Health and Food Safety adopted the report by Ivo BELET (EPP, BE) on the implementation of the Cross-Border Healthcare Directive.
Implementation
Members noted the benefits of the directive in clarifying the rules on cross-border healthcare and in ensuring access to safe and high-quality cross-border healthcare in the Union, as well as for achieving patient mobility in accordance with the case law of the Court of Justice. They expressed disappointment, however, that a significant number of Member States have not effectively implemented the requirements for guaranteeing patients’ rights, urging Member States to transpose the Directive correctly in order to ensure high-quality and accessible cross-border healthcare for patients.
The Commission was invited to proceed with its triennial evaluation reports on the operation of the Directive and to factor patient quality of life and care outcomes into its evaluation of the cost-efficiency of the implementation of the Directive, and establish guidelines on implementation.
Funding
Members recalled that while the financing of cross-border healthcare is the responsibility of Member States, the Commission, through its health programmes, supported the cooperation provided for by the Directive.
Concerned about the proposed reduction in funding for the health programme, they called for the programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027).
Patient mobility
The report stated that the reasons for low patient mobility are fourfold: i) some Member States were quite late implementing the Directive; ii) citizens’ awareness about their general rights to reimbursement is extremely low, iii) certain barriers limiting cross-border healthcare have been erected by some Member States, and iv) information on patients seeking healthcare in another Member State on the basis of the Directive is missing or incomplete.
The Commission and Member States were asked to work together to assess, realign and simplify reimbursement procedures for patients receiving cross-border care, including by clarifying the reimbursement of follow-up care and procedures, and to set up coordinating one-stop-shop front offices at the relevant healthcare insurers. The report urged the Member States to notify the Commission of any decision to introduce limitations regarding reimbursement of costs, giving their reasons for doing so.
Information for patients
The report encouraged Member States and border regions to deepen cross-border healthcare cooperation, in an efficient and financially sustainable manner, including by providing accessible, sufficient and understandable information, in order to secure the best possible care for patients. It also called on the Commission and the Member States to invest further in the development and promotion of accessible and clearly visible National Contact Points (NCPs) and eHealth platforms for patients, which should provide user-friendly, digitally accessible and barrier-free information for patients and health professionals in multiple languages.
Rare diseases, rare cancers and European Reference Networks (ERNs)
The report stressed the importance of EU-wide cooperation in ensuring the efficient pooling of knowledge, information and resources to tackle rare and chronic diseases, including rare cancers, effectively across the EU. It encouraged the Commission, in that regard, to support the setting up of specialised centres for rare diseases in the EU, which should be fully integrated into the ERNs. It also recommended building on the steps already taken to increase public awareness and understanding of rare diseases and rare cancers and to increase funding for R&D.
Mutual recognition of (e-)prescriptions
The report called on Member States and their respective health authorities to address the legal and practical issues that are hindering the mutual recognition of medical prescriptions across the EU. It also called on the Commission to take steps to ensure that prescriptions issued by ERN-linked centres of expertise are accepted for reimbursement in all Member States.
EHealth
Members acknowledged that eHealth can help to ensure that health systems are sustainable, by reducing certain costs, and can be an important part of the EU’s response to current healthcare challenges. They welcomed the creation of the EU-wide eHealth Digital Service Infrastructure, which will foster the cross-border exchange of health data, specifically e-prescriptions and patient summaries. They called on the Commission to address the digital health needs in the Member States as a matter of priority.
Brexit
The Commission was asked to negotiate a solid agreement with post-Brexit UK on health, devoting specific attention to cross-border rights for patients and the functioning of the ERNs.
Documents
2019/01/22
EP - Vote in committee
2018/12/05
EP - Amendments tabled in committee
Documents
2018/11/23
EP - Committee opinion
Documents
2018/10/30
EP - Committee draft report
Documents
2018/06/14
EP - Committee referral announced in Parliament
2018/06/14
EP - Referral to associated committees announced in Parliament
2018/04/23
EP - GRAPINI Maria (S&D) appointed as rapporteur in IMCO
2018/04/16
EP - BELET Ivo (PPE) appointed as rapporteur in ENVI
Documents
- Commission response to text adopted in plenary: SP(2019)327
- Results of vote in Parliament: Results of vote in Parliament
- Debate in Parliament: Debate in Parliament
- Decision by Parliament: T8-0083/2019
- Committee report tabled for plenary: A8-0046/2019
- Amendments tabled in committee: PE631.903
- Committee opinion: PE623.966
- Committee draft report: PE628.580
- Committee draft report: PE628.580
- Committee opinion: PE623.966
- Amendments tabled in committee: PE631.903
- Commission response to text adopted in plenary: SP(2019)327
Activities
- Ivo BELET
Plenary Speeches (2)
- Urszula KRUPA
Plenary Speeches (2)
- Soledad CABEZÓN RUIZ
Plenary Speeches (1)
- Georgios EPITIDEIOS
Plenary Speeches (1)
- José Inácio FARIA
Plenary Speeches (1)
- Arne GERICKE
Plenary Speeches (1)
- Notis MARIAS
Plenary Speeches (1)
- Momchil NEKOV
Plenary Speeches (1)
- Alojz PETERLE
Plenary Speeches (1)
- Jasenko SELIMOVIC
Plenary Speeches (1)
Votes
A8-0046/2019 - Ivo Belet - Résolution #
2019/02/12 Outcome: +: 512, 0: 62, -: 32
Verts/ALE
GUE/NGL
NI| Amendments | Dossier |
| 225 |
2018/2108(INI)
2018/09/18
IMCO
41 amendments...
Amendment 1 #
Draft opinion Citation 1 (new) - having regard to Articles 114 and 168 of the Treaty on the Functioning of the European Union (TFUE);
Amendment 10 #
Draft opinion Recital A f (new) A f. whereas the result of the implementation of the current Directive shows that in 2015 not all the Member States implemented completely or correctly the Directive;
Amendment 11 #
Draft opinion Recital A g (new) A g. whereas in terms of data, not all the Member States were able to supply data or information regarding the patient travelling abroad; whereas data collection is not always comparable from one Member State to another;
Amendment 12 #
Draft opinion Paragraph 1 1. Notes the benefits of Directive 2011/24/EU in clarifying the rules on cross-border healthcare and in ensuring access to safe and high-quality cross- border healthcare in the Union, as well as for achieving patient mobility in accordance with the case-law of the Court of Justice;
Amendment 13 #
Draft opinion Paragraph 1 1 Notes the benefits of Directive 2011/24/EU in clarifying the rules on cross-border healthcare and in ensuring access to safe and high-quality cross- border healthcare in the Union, as well as for achieving patient mobility in accordance with the case-law of the Court of Justice; urges Member States to ensure its proper implementation, guaranteeing a high level of public health protection that contributes to the improvement of citizens’ health, while respecting the principle of the free movement of persons within the internal market; stresses the focus of the Directive should be on addressing the imbalances between Member State healthcare and improving patients' rights rather than seeking to boost privatisation of the healthcare sector in different Member States in order to foster more market competition between healthcare providers within the single market.
Amendment 14 #
Draft opinion Paragraph 1 a (new) 1 a. Encourages the Commission to review the real situation of cross-border healthcare in the Union more often than it is required as a minimum, according to Article 20 of Directive 2011/24/EU; considers it useful for the Commission to review the situation annually and to present a report to the Parliament at least every two years;
Amendment 15 #
Draft opinion Paragraph 1 a (new) 1 a. Recalls that Article 8(2)(a) of Directive 2011/24/EU allows Member States to use a system of prior authorisation for healthcare that is subject to planning requirements if it involves overnight hospital accommodation or if it requires use of highly specialised and cost-intensive medical infrastructure or medical equipment, insists however, that any system of prior authorisation must be necessary and proportionate to the objective to be achieved, and may not constitute a means of arbitrary discrimination or an unjustified obstacle to the free movement of patients;
Amendment 16 #
Draft opinion Paragraph 1 b (new) 1 b. Deplores that in a significant number of Member States, it is still unclear for patients exactly which treatments are subject to prior authorisation, urges Member States to clarify how they use the criteria “overnight stay” and “highly specialised care” so that those are clearly understandable for patients and authorities;
Amendment 17 #
Draft opinion Paragraph 1 c (new) 1 c. Recalls that, although Article 7(9) of the Directive permits Member States to limit the application of the rules on reimbursement of cross-border healthcare for overriding reasons of general interest, Article 7(11) requires that such limitations be necessary and proportionate; urges Member States to facilitate the reimbursement of cross- border healthcare;
Amendment 18 #
Draft opinion Paragraph 1 d (new) 1 d. Regrets that application of the Directive to ‘telemedicine’ has led to a certain lack of clarity, as some Member States reimburse or provide consultations with general practitioners at a distance, whilst others do not; encourages Member States to harmonize the way their reimburse ´telemedicine´;
Amendment 19 #
Draft opinion Paragraph 2 a (new) 2 a. Underlines the importance for healthcare providers and professionals to have professional civil liability insurance, as provided for in Directives 2005/36/EC and 2011/24/EU, in order to improve the quality of health services and to increase patient protection;
Amendment 2 #
Draft opinion Citation 1 a (new) - having regard to Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross- border healthcare;
Amendment 20 #
Draft opinion Paragraph 2 a (new) 2 a. Notes that collection of data is not comparable from one Member State to another; encourages therefore the Commission to establish a common framework to assess properly the benefits of Directive2011/24/EU and allow comparison between Member States;
Amendment 21 #
Draft opinion Paragraph 2 a (new) 2 a. Urges Member States to address the remaining issues concerning the mutual recognition of medical prescriptions between Member States;
Amendment 22 #
Draft opinion Paragraph 2 a (new) 2a. Highlights the importance to collect and have available the data for patients travelling abroad for treatment, and calls upon the Commission to address this matter through a European Record for patients;
Amendment 23 #
Draft opinion Paragraph 2 a (new) 2 a. Recommends the Commission to develop guidelines on informing patients about step-by-step procedures for using the cross-border health care services and to create standardised templates for all types of forms required in cross-border healthcare, in cooperation with the involvement of patient organisations;
Amendment 24 #
Draft opinion Paragraph 2 b (new) 2b. Underlines that digitalization could bring an added value to the implementation of the Directive, and e- health interoperability should be a priority to improve global patient records and continuity of care.
Amendment 25 #
Draft opinion Paragraph 2 b (new) 2 b. Recommends to Member States to publish accurate and easily understandable information about step- by-step procedures for using the cross- border health care services;
Amendment 26 #
Draft opinion Paragraph 2 c (new) 2c. Calls on the Commission to put in place a mechanism where patients should be able to address complaints in cases where their rights have been not respected or even violated;
Amendment 27 #
Draft opinion Paragraph 2 c (new) 2 c. Asks Member States and National Contact Points to inform patients beyond generic information, such as links to national laws or regulatory documents and to provide practical and easily understandable complex legal and medical information;
Amendment 28 #
Draft opinion Paragraph 3 a (new) 3 a. Recommends the Commission to establish and publish benchmarks and key indicators for quality of healthcare and patient safety and compare information across institutions and Member States;
Amendment 29 #
Draft opinion Paragraph 3 a (new) 3 a. Notes the continued success of the European Health Insurance Card and the positive impact this has had on the lives of many who have made use of it throughout the EU and EEA.
Amendment 3 #
Draft opinion Citation 1 b (new) - having regard to the Commission communication of 25 April 2018 on enabling the digital transformation of health and care in the Digital Single Market ; empowering citizens and building a healthier society;
Amendment 30 #
Draft opinion Paragraph 3 b (new) 3 b. Notes that the Directive fundamentally is failing to address widening health inequalities across the EU and that those from poorer countries are still unable to access much-needed specialist treatment in other Member States.
Amendment 31 #
Draft opinion Paragraph 4 a (new) 4 a. Reminds that eHealth applications are financed or co-financed from the Union´s budget, therefore highlights the Commission should more actively address the lack of interoperability between Member States’ eHealth solutions;
Amendment 32 #
Draft opinion Paragraph 4 b (new) 4 b. Asks the Commission to identify the Member States with interoperable and properly functioning eHealth solutions and their individual functionalities;
Amendment 33 #
Draft opinion Paragraph 5 5.
Amendment 34 #
Draft opinion Paragraph 5 5. Stresses the importance of information to patients about their rights and the procedures, costs and reimbursement rates in cross-border healthcare within the framework of Directive 2011/24/EU; invites the Commission to take measures to increase patients’ awareness about their rights and about the National Contact Points. Member States should collaborate to promote national safety and quality standards.
Amendment 35 #
Draft opinion Paragraph 5 5. Stresses the importance of comprehensive, easy-to-understand and easy-to-access information to patients about their rights and the procedures, costs and reimbursement rates in cross-border healthcare within the framework of Directive 2011/24/EU; invites the Commission to take measures to increase patients’ awareness about their rights and about the National Contact Points.
Amendment 36 #
Draft opinion Paragraph 5 a (new) 5 a. Regrets that patient mobility for planned healthcare remains low, whilst patient mobility in terms of unplanned healthcare seems tobe considerably higher, highlights that the level of use of planned healthcare elsewhere is far below the potential levels suggested by the number of people indicating in the Eurobarometer survey that they would consider using cross-border healthcare, encourages therefore Member States to do their outmost to raise awareness among citizens on the general rights under the Directive;
Amendment 37 #
Draft opinion Paragraph 5 a (new) 5 a. Highlights in this regard the key role of National Contact Points in providing information to patients on their rights, procedures, costs and reimbursements as well as complaint mechanisms in order to help them taking a decision; Calls therefore for the allocation of appropriate resources and staff in order to ensure their proper functioning and invite the Commission to define common guidelines for National Contact Points on the core information to be delivered to patients;
Amendment 38 #
Draft opinion Paragraph 5 a (new) 5 a. Welcomes the pending audit of the European Court of Auditors on whether implementation of the Directive to date has been effective, and whether cross- border healthcare is delivering benefits to patients; strongly encourages the Commission and the Member States to take the recommendations of this audit into account;
Amendment 39 #
Draft opinion Paragraph 5 a (new) 5 a. Calls on the Commission and the Member States to work towards and propose joint, simplified and explicit healthcare measures for citizens in cross- border situations in the Union to increase public health protection.
Amendment 4 #
Draft opinion Recital A (new) A. Whereas according to Article 20 of Directive 2011/24/EU , the Commission is expected to present an implementation report on the operation of that directive every 3 years; whereas the Commission should constantly assess and regularly present information on patient flows , on the administrative , social and financial dimensions of patient mobility and on the functioning of the European reference networks and national contact points;
Amendment 40 #
Draft opinion Paragraph 5 b (new) 5 b. Notes that citizens , and in particular patients, as well as healthcare professionals, providing services abroad , either experience difficulty in finding and understanding the information on the applicable rules and procedures in other Member States or are not aware of their rights; calls on the Commission to improve the functioning of the national contact points, in order to promote regular exchange of information which is comprehensive and user-friendly so that citizens and professionals traveling abroad can make well-informed decisions and save time and costs; considers that each Member State must be responsible for the accuracy of the information provided via National Contact Points;
Amendment 41 #
Draft opinion Paragraph 5 b (new) 5 b. Encourages Member States to highly consider the undue delay rule of reimbursement for cross-border health care services introduced by Directive and not to apply burdensome requirements not justified by Directive such as documents certified by a consul in the country of treatment, a sworn translation of invoices or a referral from a medical professional in the home country, annual reimbursement limit for cross-border care;
Amendment 5 #
Draft opinion Recital A a (new) A a. Whereas further clarity and transparency for the conditions under which healthcare providers are operating is needed in order to secure safe patient mobility;
Amendment 6 #
Draft opinion Recital A b (new) A b. Whereas the Commission communication on e-health notes that health and care systems require reforms and innovative solutions to become more resilient, accessible and effective; whereas therefore the use of new technologies and digital tools should be strengthened to attain greater quality and sustainability of healthcare services;
Amendment 7 #
Draft opinion Recital A c (new) A c. Whereas according to a 2015 Eurobarometer survey, less than 20% of citizens were aware of their rights regarding cross-border healthcare;
Amendment 8 #
Draft opinion Recital A d (new) A d. Whereas according to the 2015 Commission report on the operation of Directive2011/24/EU on the application of patients’ rights in cross-border healthcare, it remains difficult for citizens to find out how they can use their rights in terms of cross-border healthcare;
Amendment 9 #
Draft opinion Recital A e (new) A e. whereas there is still a considerable number of Member States where obstacles placed in the way of patients by health systems are significant and it only deepens the fragmentation of the access to services;
source: 627.772
2018/12/05
ENVI
184 amendments...
Amendment 1 #
Motion for a resolution Citation 4 — having regard to Council Conclusions of 6 June 2011 on moving towards modern, responsive, affordable-to- all and sustainable health systems3 , _________________ 3 OJ C 202, 8.7.2011, p. 10.
Amendment 10 #
Motion for a resolution Recital A a (new) Aa. whereas health protection is an important value for European citizens and the public health system is seen as crucial for preserving and guaranteeing universal access to health;
Amendment 100 #
Motion for a resolution Paragraph 7 7.
Amendment 101 #
Motion for a resolution Paragraph 7 7. Asks the Commission to continue the structured dialogues with Member States, providing greater clarity regarding cases where prior authorisation is required and the associated conditions for reimbursement
Amendment 102 #
Motion for a resolution Paragraph 7 a (new) 7 a. Asks the European Commission to develop guidelines for the Member States to compare, if prior authorisation is installed, treatments abroad with the treatment available in the own Member Sate with cost-effectivity for patients as the guiding principle;
Amendment 103 #
Motion for a resolution Paragraph 8 8. Reminds the Member States that
Amendment 104 #
Motion for a resolution Paragraph 8 a (new) 8a. Notes with concern that in some Member States insurance companies have discriminated arbitrarily or created unjustified obstacles to the free movement of patients and services, with adverse financial consequences for patients;
Amendment 105 #
Motion for a resolution Paragraph 8 a (new) 8 a. Calls on the Commission to put in place a mechanism where patients should be able to address complaints in cases where their rights have been not respected or even violated;
Amendment 106 #
Motion for a resolution Paragraph 9 9. Urges the Member States to notify the Commission of any decision to introduce limitations regarding reimbursement of costs under Article 7(9) of the directive, giving its reasons for doing so;
Amendment 107 #
Motion for a resolution Paragraph 10 10. Regrets the fact that some Member States grant lower levels of reimbursement for cross-border healthcare supplied by private or non-contracted healthcare providers on their own territories than for that supplied by public or contracted healthcare providers; considers that reimbursement for private healthcare at the same level as for public healthcare should be guaranteed, provided that the quality and safety of care are ensured;
Amendment 108 #
Motion for a resolution Paragraph 10 10. Regrets the fact that some Member States grant lower levels of reimbursement for cross-border healthcare supplied by private or non-contracted healthcare providers on their own territories than for that supplied by public or contracted healthcare providers, or have lowered the limits for healthcare services for their citizens, forcing them to travel to a neighbouring Member State for treatment;
Amendment 109 #
Motion for a resolution Paragraph 10 10. Regrets the fact that some Member States sometimes grant lower levels of reimbursement for cross-border healthcare supplied by private or non-contracted healthcare providers on their own territories than for that supplied by public or contracted healthcare providers;
Amendment 11 #
Motion for a resolution Recital A b (new) Ab. having regard to Article 168(7) of the Treaty on the Functioning of the European Union, which establishes that the organisation of health systems and the delivery of services are matters for the individual Member States;
Amendment 110 #
Motion for a resolution Paragraph 10 10.
Amendment 111 #
Motion for a resolution Paragraph 11 11.
Amendment 112 #
Motion for a resolution Paragraph 11 11. Asks the Commission and the Member States to work together to assess, realign and drastically simplify reimbursement procedures for patients receiving cross-border care, including the need for up-front payments and clarification of reimbursement of follow- up care and procedures, and to install a one-stop-shop front office;
Amendment 113 #
Motion for a resolution Paragraph 11 11. Asks the Commission and the Member States to work together to assess, realign and drastically simplify reimbursement procedures for patients receiving cross-border care, and to install
Amendment 114 #
Motion for a resolution Paragraph 11 11. Asks the Commission and the Member States to work together to assess, realign and
Amendment 115 #
Motion for a resolution Paragraph 12 12. Calls on the Commission to ensure that the rules regarding reimbursement under Article 7(1) and Article 4(1) a
Amendment 116 #
Motion for a resolution Paragraph 12 a (new) 12 a. Notes with concern that in certain Member States policies and legal provisions are under discussion, in the context of regulating population screening, which would introduce additional requirements to license preventive medical tests, scans and health checks carried out in other Member States; asks the Commission to defend the freedom of citizens in the Union to provide or receive services1a and actively monitor ongoing developments in Member States in this field; _________________ 1a Art. 56 TFEU.
Amendment 117 #
Motion for a resolution Paragraph 12 a (new) 12 a. Regrets that application of the Directive on 'telemedicine’ has led to a certain lack of clarity in regards to reimbursement schemes, as some Member States reimburse or provide consultation with general practitioners at a distance, whilst others do not; encourages Member States to align the way they reimburse telemedicine;
Amendment 118 #
Motion for a resolution Paragraph 12 a (new) 12a. Calls on Member States to take into consideration the difficulties faced by low-income patients who have to pay for cross-border treatment in advance;
Amendment 119 #
Motion for a resolution Paragraph 13 13. Encourages the Member States and border regions to deepen cross-border healthcare cooperation, in an efficient and financially sustainable manner, in order to secure the best possible care for patients; asks the Commission to support and stimulate a structural exchange of best practices among border regions; calls on the Member States to provide sufficient information so as to ensure that persons requiring cross-border healthcare receive the right assistance, including when it comes to speeding up and ensuring they understand the entire administrative process;
Amendment 12 #
Motion for a resolution Recital B B. whereas Directive 2011/24/EU respects the freedom of each Member State to make the appropriate healthcare decisions and does not interfere with or undermine the fundamental ethical choices of the relevant authorities within the Member States;
Amendment 120 #
Motion for a resolution Paragraph 13 13. Encourages the Member States and border regions to deepen cross-border healthcare cooperation, in an efficient and financially sustainable manner, in order to secure the best possible care for patients; asks the Commission to support and stimulate a structural exchange of best practices among border regions; encourages the Member States to use these best practices to also improve healthcare in other regions;
Amendment 121 #
Motion for a resolution Paragraph 13 13. Encourages the Member States and border regions to deepen cross-border healthcare cooperation, in an efficient and financially sustainable manner, in
Amendment 122 #
Motion for a resolution Paragraph 13 13. Encourages the Member States
Amendment 123 #
Motion for a resolution Paragraph 14 14.
Amendment 124 #
Motion for a resolution Paragraph 15 15.
Amendment 125 #
Motion for a resolution Paragraph 15 15.
Amendment 126 #
Motion for a resolution Paragraph 15 15. Calls on the Commission and the Member States to invest further in the development of highly accessible and clearly visible NCPs and eHealth platforms for patients, which provide user- friendly information for patients and health professionals;
Amendment 127 #
Motion for a resolution Paragraph 15 15. Calls on the Commission and the Member States to invest further in the development of highly accessible and clearly visible NCPs which provide comprehensive, barrier-free, user-
Amendment 128 #
Motion for a resolution Paragraph 15 15. Calls on the Commission and the Member States to invest further in the development and promotion of highly accessible and clearly visible NCPs which provide user-
Amendment 129 #
Motion for a resolution Paragraph 15 15. Calls on the Commission and the Member States to invest further in the development of
Amendment 13 #
Motion for a resolution Recital B a (new) Ba. whereas the directive recognises the right to choose a method of treatment that differs from that provided in the Member State of affiliation, or healthcare that is of better quality than that provided in the Member State of affiliation; whereas this takes place within the public system – as the private system is based on free choice – and can place an economic burden on Member States regarded as attractive on account of their high-quality healthcare, and bearing in mind that the Member State’s costs are based on the costs of the Member State providing the healthcare; whereas the above can constitute discrimination depending on the economic circumstances of the patients travelling;
Amendment 130 #
Motion for a resolution Paragraph 15 a (new) 15 a. Calls on the Commission and the Member States to strengthen citizens’ digital literacy with a clear purpose to be more innovative and bold in using new digital opportunities;
Amendment 131 #
Motion for a resolution Paragraph 15 b (new) 15 b. Urges the Commission and the Member States to speed up with the development of EU level policy recommendations focusing on how to stimulate in a best way an emerging Silver Economy in Europe; stresses the need to lower barriers to create suitable products, services and scale up new solutions for ageing population;
Amendment 132 #
Motion for a resolution Paragraph 16 16. Recommends that the Commission
Amendment 133 #
Motion for a resolution Paragraph 16 16. Recommends that the Commission develops guidelines on the functioning of the NCPs and further facilitates and improves the structural exchange of information and practices between them with the goal of producing harmonised, simplified and patient-friendly procedures and forms;
Amendment 134 #
Motion for a resolution Paragraph 16 16. Recommends that the Commission develop guidelines on the functioning of the NCPs
Amendment 135 #
Motion for a resolution Paragraph 17 17. Calls on the Member States to provide sufficient funding for their NCPs to be able to develop comprehensive information, and asks the Commission to intensify cooperation between the NCPs across the Union; calls on the Member States, furthermore, to draw up an accessible manual for each Member State, in line with the manual drawn up by the Commission;
Amendment 136 #
Motion for a resolution Paragraph 17 17. Calls on the Member States to provide sufficient funding for their NCPs to be able to develop comprehensive information, and asks the Commission to intensify cooperation
Amendment 137 #
Motion for a resolution Paragraph 17 a (new) 17 a. Stresses the potential of eHealth to improve the access of patients to information on the possibilities of cross border healthcare and on patients’ rights under the directive;
Amendment 138 #
Motion for a resolution Paragraph 17 b (new) 17 b. Calls on the Member States to urge health care providers and hospitals to provide patients beforehand with an accurate and up to date cost estimate of the treatment abroad, including medicines, honoraria, overnight stays and supplementary fees;
Amendment 139 #
Motion for a resolution Paragraph 18 18. Asks the Commission to clarify, for the benefit of national experts and by means of information campaigns, the complexity of the current legal situation deriving from the interaction between the directive and the regulation
Amendment 14 #
Motion for a resolution Recital B a (new) Ba. whereas health can be regarded as a fundamental right under Article 2, ‘Right to life’ and Article 35, ‘Health care’ of the Charter of Fundamental Rights of the European Union;
Amendment 140 #
Motion for a resolution Paragraph 19 19. Asks the Commission to organise, in conjunction with the competent national authorities, NCPs, ERNs, patient organisations and networks of healthcare professionals, information campaigns designed to foster structural awareness of patients’ rights under the directive;
Amendment 141 #
Motion for a resolution Paragraph 19 a (new) 19 a. Calls on the Commission to address the Member States to put in place a mechanism where patients can file complaints in cases where their rights under the Directive have been not respected or even violated;
Amendment 142 #
Motion for a resolution Paragraph 19 a (new) 19a. Calls on the Commission to publish and analyse, on an annual basis, the reasons why patients move between countries;
Amendment 143 #
Motion for a resolution Paragraph 19 b (new) 19 b. Recommends that the Commission develops guidelines on the type of information the NCPs should give, in particular concerning the list of treatments which are subject to prior authorization and those which are not, the criteria applied, the procedures etc;
Amendment 144 #
Motion for a resolution Paragraph 19 b (new) 19b. Calls on the Commission to publish, on an annual basis, the services provided;
Amendment 145 #
Motion for a resolution Paragraph 19 c (new) 19c. Calls on the Commission and the Member States to assess the need to identify the reasons for granting access to cross-border healthcare in a way that guarantees free movement, but without healthcare being an end in itself as long as the organisation of health systems is a national competence;
Amendment 146 #
Motion for a resolution Paragraph 19 d (new) 19d. Calls for the pricing system to be reviewed so as to ensure that no burden is placed on public health systems, that patients are not encouraged to travel from one country to another for economic reasons, that the country delivering the service has no economic incentive do to so, and that pricing can help keep health systems sustainable;
Amendment 147 #
Motion for a resolution Subheading 6 Rare diseases, Rare Cancers and European Reference Networks (ERNs)
Amendment 148 #
Motion for a resolution Paragraph 20 20. Stresses the importance of EU-wide cooperation in ensuring the efficient pooling of knowledge and resources to tackle rare diseases, including rare cancers, effectively across the EU;
Amendment 149 #
Motion for a resolution Paragraph 20 20. Stresses the importance of EU-wide cooperation in ensuring the
Amendment 15 #
Motion for a resolution Recital B b (new) Bb. whereas the entitlement to cross- border healthcare and to the European Health Insurance Card is dependent on being an ‘insured person’ in the country of affiliation, and this can vary among Member States;
Amendment 150 #
Motion for a resolution Paragraph 20 a (new) 20 a. Urges the Commission to address the low rate of rare diseases registration and develop a common standard for the exchange of data in rare disease registries;
Amendment 151 #
Motion for a resolution Paragraph 21 21. Encourages the steps already taken to increase public awareness and understanding of rare diseases and to increase funding for R&D; points out that even diseases with a very low incidence must be able to receive sufficient support;
Amendment 152 #
Motion for a resolution Paragraph 21 21. Encourages the steps already taken to increase public awareness and understanding of rare diseases and rare cancers, and to increase funding for R&D;
Amendment 153 #
Motion for a resolution Paragraph 21 21.
Amendment 154 #
Motion for a resolution Paragraph 21 a (new) 21 a. Stresses a necessity for improving patient adherence models which are based on the most stable findings from meta- analyses and large-scale empirical studies, reflecting the realities of medical practice and offering recommendations for enhancing patient’s dedication to treatment, particularly in chronic disease management, which is a key factor for measuring the efficiency and effectiveness of the healthcare systems;
Amendment 155 #
Motion for a resolution Paragraph 21 a (new) 21 a. Encourages the Commission to guarantee access to information, medicines and medical treatment for rare disease patients throughtout the EU, to promote better coordination and learning across Member States and to strive for an improved access to early and accurate diagnosis;
Amendment 156 #
Motion for a resolution Paragraph 21 a (new) 21 a. Underlines the importance and added value of EU-wide mobility of health care professionals, both during their educational and professional careers, especially to improve knowledge and expertise on rare diseases;
Amendment 157 #
Motion for a resolution Paragraph 22 22. Proposes that the Commission should open a fresh call for the development of new ERNs and should continue to support the development and scaling up of the ERN model, in order to overcome geographical differences and gaps in expertise; stresses, however, that any extension of ERNs must not undermine the operation of existing ERNs during their initial phase;
Amendment 158 #
Motion for a resolution Paragraph 23 a (new) 23 a. Encourages Member States to integrate ERNs into the National Rare Diseases Plans and National Cancer Plans;
Amendment 159 #
Motion for a resolution Paragraph 24 24. Urges the Commission to implement an action plan for the further development and sustainable financing of the ERNs and patient's networks supporting them, via the European Joint Programme on Rare Diseases;
Amendment 16 #
Motion for a resolution Recital C C. whereas healthcare systems in the EU are facing challenges due to an ageing population, the emergence of health technologies, the high prices of medicines that in many cases do not add therapeutic value, the lack of new treatments for certain illnesses and budgetary constraints;
Amendment 160 #
Motion for a resolution Paragraph 25 25. Regrets the difficulties faced by patients in securing access to and reimbursement for medicines in other Member States, owing to differing availabilities and rules across the EU and to the burdensome administrative constraints imposed;
Amendment 161 #
Motion for a resolution Paragraph 25 25. Regrets the difficulties faced by patients in
Amendment 162 #
Motion for a resolution Paragraph 25 a (new) 25 a. Calls on the Member States and their respective health authorities to address the legal and practical issues that are hindering the mutual recognition of medical prescriptions across Member States and urges the Commission to take supportive action in this regard;
Amendment 163 #
Motion for a resolution Paragraph 25 a (new) 25a. Calls on the Commission to draw up an action plan to systematically address excessively high medicine prices and the large disparities in them between the various Member States;
Amendment 164 #
Motion for a resolution Paragraph 26 26.
Amendment 165 #
Motion for a resolution Paragraph 27 27. Welcomes the support from the Connecting Europe Facility (CEF) as part of efforts to ensure that current pilot projects on the exchange of e-prescriptions and patient summaries are successfully developed and pave the way for other Member States to follow by 2020; insists on the continuation of this support in the next Multiannual Financial Framework;
Amendment 166 #
Motion for a resolution Paragraph 27 27. Welcomes the support from the Connecting Europe Facility (CEF) as part of efforts to
Amendment 167 #
Motion for a resolution Paragraph 28 28. Acknowledges that eHealth can help to ensure that health systems are sustainable and can be an important part of the EU’s response to the healthcare challenges of today; supports healthcare information exchange amongst Member States through inclusive digitalisation, whilst guaranteeing patients privacy; considers that special attention should be paid to allowing easy access to care for all patients; believes that exclusion through digitalisation shall by all means be avoided;
Amendment 168 #
Motion for a resolution Paragraph 28 28. Acknowledges that eHealth can help to ensure that health systems are sustainable and can be an important part of the EU’s response to the healthcare challenges of today; urges further focus on the accessibility considerations of eHealth to ensure it does not by means of unintended outcomes lead to greater inequality in access to health care particularly among elderly and disabled;
Amendment 169 #
Motion for a resolution Paragraph 28 28. Acknowledges that eHealth can help to ensure that health systems are sustainable and can be an important part of the EU’s response to the healthcare challenges of today; underlines that eHealth interoperability should be a priority to improve global patient records and continuity of care;
Amendment 17 #
Motion for a resolution Recital C C. whereas healthcare systems in the EU are facing challenges due to an ageing population
Amendment 170 #
Motion for a resolution Paragraph 28 28. Acknowledges that eHealth can help to
Amendment 171 #
Motion for a resolution Paragraph 28 28.
Amendment 172 #
Motion for a resolution Paragraph 28 a (new) 28 a. Stresses that citizens should have secure access to a comprehensive electronic record of their health data, and should remain in control of and be able to share their personal health data securely with authorised parties, while unauthorised access should be prevented in accordance with data protection legislation;
Amendment 173 #
Motion for a resolution Paragraph 29 29. Welcomes the creation of the EU- wide eHealth Digital Service Infrastructure (eHDSI), which will foster the cross-border exchange of health data, specifically e- prescriptions and patient summaries; calls, in that connection, for proper data protection to be guaranteed;
Amendment 174 #
Motion for a resolution Paragraph 29 a (new) 29 a. Underlines the importance of monitoring the implementation of the General Data Protection Regulation and the Regulation on electronic identification and trust services for electronic transactions in the internal market with regard to health;
Amendment 175 #
Motion for a resolution Paragraph 29 a (new) 29 a. Encourages the Commission to support the set-up of specialised centres for rare diseases in the EU, fully integrated in the ERNs;
Amendment 176 #
Motion for a resolution Paragraph 30 30.
Amendment 177 #
Motion for a resolution Paragraph 30 30. Urges the Member States to take swift action to connect their health systems to the eHDSI through a
Amendment 178 #
Motion for a resolution Paragraph 30 a (new) 30 a. Asks Member States to further intensify the cooperation between the Member States' health authorities across Europe, in order to connect e-health data and personal records with ePrescribing tools, enabling health care professionals to deliver personalised and well informed care towards their patients while fully respecting EU data protection legislation in this regard; calls on the Commission to take action to facilitate such actions;
Amendment 179 #
Motion for a resolution Paragraph 30 a (new) 30a. Calls on the Member States to adapt to the facilities provided by the Union using corresponding digital eHealth services, and to create a digital tool to improve cooperation and information exchange among doctors who are required to meet these needs;
Amendment 18 #
Motion for a resolution Recital C C. whereas healthcare systems in the EU are facing challenges
Amendment 180 #
Motion for a resolution Paragraph 30 a (new) 30 a. Notes that the personalised medical services and therapies should be adjusted to the individual needs of patients across the European Union with a secure method of transferring health data in accordance to Regulation (EU) 2016/679 (General Data Protection Regulation);
Amendment 181 #
Motion for a resolution Paragraph 30 b (new) 30 b. Calls on the Commission to address as a priority the digital health needs in the Member States; welcomes the Commission’s support of sustained financial resources to ensure a strong national digital health strategy and create a suitable framework for common actions at the European level to prevent fragmentation of efforts and ensure the exchange of best practices for wider usage of digital technology in the Member States;
Amendment 182 #
Motion for a resolution Paragraph 30 b (new) 30 b. Calls on the Member States to swiftly implement the EU data protection legislation in place in order to assure the safety of patients’ data used in eHealth applications; stresses the need to enable citizens to access and use their own health data, in accordance with the principles laid down in the General Data Protection Regulation;
Amendment 183 #
Motion for a resolution Paragraph 31 31. Asks the Commission
Amendment 184 #
Motion for a resolution Paragraph 32 32. Calls on the Member States to implement
Amendment 19 #
Motion for a resolution Recital C C. whereas healthcare systems in
Amendment 2 #
Motion for a resolution Citation 10 a (new) - having regard to the Commission communication of 25 April 2018 on enabling the digital transformation of health and care in the Digital Single Market; empowering citizens and building a healthier society (COM(2018)0233),
Amendment 20 #
Motion for a resolution Recital C C. whereas healthcare systems in the EU are facing challenges due to an ageing population
Amendment 21 #
Motion for a resolution Recital D D. whereas the healthcare that citizens need may sometimes be best provided in another Member State, on account of proximity, ease of access, knowledge of the health market in a neighbouring EU country, the specialised nature of care or a lack of capacity in their own Member State;
Amendment 22 #
Motion for a resolution Recital D D. whereas the healthcare that citizens need may sometimes be best provided in another Member State, on account of proximity, the specialised nature of care or a lack of capacity, such as shortages of essential medicines, in their own Member State;
Amendment 23 #
Motion for a resolution Recital D a (new) D a. whereas the result of the implementation of the current Directive shows that in 2015 not all the Member States implemented completely or correctly the Directive;
Amendment 24 #
Motion for a resolution Recital E E. whereas the health sector
Amendment 25 #
Motion for a resolution Recital E E. whereas the health sector is a vital part of the EU economy, amounting to 10 % of its GDP – a figure that could rise to 12.6 % by 2060 owing to socio-economic factors (demographics, social structure, prosperity of the population) as well as political factors;
Amendment 26 #
Motion for a resolution Recital E E. whereas the health sector is a vital part of the EU economy, amounting to 10 % of its GDP – a figure that could
Amendment 27 #
Motion for a resolution Recital E a (new) E a. whereas quality of life for the patient and patient outcomes have been increasingly recognised as important components of healthcare cost-efficiency assessment;
Amendment 28 #
Motion for a resolution Recital E a (new) E a. whereas EU citizens have the right to access specialised care in their own Member State, where it is available;
Amendment 29 #
Motion for a resolution Recital F F. whereas the directive provides a clear legal basis for European cooperation and collaboration with regard to health technology assessment (HTA), eHealth,
Amendment 3 #
Motion for a resolution Citation 13 a (new) - having regard to the Recommendations on Rare Disease European Reference Networks of the European Union Committee of Experts on Rare Diseases (EUCERD) of 31 January 2013 and its Addendum of 10 June 2015,
Amendment 30 #
Motion for a resolution Recital F F. whereas the directive provides a clear legal basis for European cooperation and collaboration with regard to
Amendment 31 #
Motion for a resolution Recital F F. whereas the directive provides a
Amendment 32 #
Motion for a resolution Recital G a (new) Ga. whereas vaccination programmes are not covered by the directive, even though they are one of the policies with the most impact, and bearing in mind the difficulties that some Member States have in accessing them;
Amendment 33 #
Motion for a resolution Recital G a (new) G a. whereas there is still a considerable number of Member States where obstacles placed in the way of patients by health systems are significant and it only deepens the fragmentation of the access to services;
Amendment 34 #
Motion for a resolution Recital G a (new) G a. whereas not all Member States were able to supply data or information regarding patient mobility;
Amendment 35 #
Motion for a resolution Recital G b (new) Gb. Whereas cross-border healthcare should be geared towards guaranteeing mobility for EU citizens, and whereas the European Health Insurance Card, an essential tool in that regard, is regulated by the Regulation on the Coordination of Social Security Systems, and its implementation varies widely among the various Member States;
Amendment 36 #
Motion for a resolution Recital G b (new) G b. whereas 83% of the population is willing to provide medical data if it is used for research and to improve patient's health condition; 2a _________________ 2a https://ec.europa.eu/health/sites/health/fil es/ehealth/docs/2018_consultation_dsm_e n.pdf
Amendment 37 #
Motion for a resolution Recital H H. whereas patient mobility in the EU remains relatively low and has not had a significant budgetary impact on the
Amendment 38 #
Motion for a resolution Recital H H. whereas, at present, patient mobility in the EU remains relatively low and has not had a significant budgetary impact on the sustainability of the national health systems; and whereas, in future, patient mobility might increase to a varying extent owing to different socio- economic and political factors;
Amendment 39 #
Motion for a resolution Recital H H. whereas patient mobility in the EU remains relatively low and has not had a significant budgetary impact on the sustainability of the national health systems, owing to fears among the Member States that the directive will promote health tourism rather than mobility;
Amendment 4 #
Motion for a resolution Citation 18 a (new) - having regard to Regulation (EU) 2016/679 of the European Parliament and of the Council of 27April 2016 on the protection of natural persons with regard to processing of personal data and on the free movement of such data (GDPR).1a _________________ 1a OJ L 119, 4.5.2016, p. 1–88
Amendment 40 #
Motion for a resolution Recital H H. whereas patient mobility in the EU remains relatively low under the scope of the Directive and has not had a significant budgetary impact on the sustainability of the national health systems;
Amendment 41 #
Motion for a resolution Recital H a (new) Ha. whereas the organisation of health systems is an exclusive competence of the Member States, and whereas there are differences not only in the services provided but also in the way they are funded;
Amendment 42 #
Motion for a resolution Recital I I. whereas the Member States are responsible for providing access to the healthcare that people require and for ensuring that the relevant costs are
Amendment 43 #
Motion for a resolution Recital I I. whereas the Member States are responsible for providing access to the healthcare that people require and for ensuring that the relevant costs are reimbursed; whereas the Member States’ national healthcare services are responsible for setting the criteria permitting citizens to receive healthcare in another Member State; whereas the Member States are responsible for developing and keeping an updated catalogue of medicines shortages to ensure the availability of essential medicines;
Amendment 44 #
Motion for a resolution Recital I I. whereas the Member States are responsible for providing access to the healthcare that people require and for ensuring that
Amendment 45 #
Motion for a resolution Recital I a (new) Ia. whereas freedom of movement must not give rise to discrimination in relation to healthcare; whereas different national criteria can give rise to discrimination in accessing the European Health Insurance Card, and ultimately in accessing healthcare; whereas the right to health must not restrict freedom of movement;
Amendment 46 #
Motion for a resolution Recital I a (new) I a. whereas patients still face practical and legal difficulties when using medical prescriptions across Member States;
Amendment 47 #
Motion for a resolution Recital J a (new) Ja. whereas patients are insufficiently informed of their cross-border healthcare rights and, in any case, fewer than two Europeans out of ten consider themselves to be well informed on the relevant rights, according to a Eurobarometer survey in 20151 a; _________________ 1a Special Eurobarometer 425: 'Patients’ rights in cross-border healthcare in the European Union' (2015)
Amendment 48 #
Motion for a resolution Recital J a (new) Ja. whereas the movement of patients between certain countries is very marked, such as from France to Spain, between France and Germany, and from Poland to neighbouring Member States;
Amendment 49 #
Motion for a resolution Recital K K. whereas the efficiency and outreach of the NCPs depends on the support that they receive from both the EU and the Member States and the mechanisms for communication, exchange of good practices and information, including contact information, and guidelines for referral of patients that are established;
Amendment 5 #
Motion for a resolution Recital A A. whereas health systems in the
Amendment 50 #
Motion for a resolution Recital K a (new) Ka. Whereas NCPs are not yet sufficiently well known to the public, which has an impact on their effectiveness;
Amendment 51 #
Motion for a resolution Recital L L. whereas there are large variations between the various NCPs with regard to the functioning, including accessibility to citizens, visibility and allocation of resources;
Amendment 52 #
Motion for a resolution Recital L L. whereas there are large variations between the various NCPs with regard to the functioning, visibility and allocation of resources, in terms of both quality and quantity;
Amendment 53 #
Motion for a resolution Recital L a (new) La. whereas, given that medical records and information are important in facilitating patient mobility, any future integration of health systems must, from a digital point of view, guarantee that the health systems are the ultimate custodians and managers of the information concerned, so as to guarantee fairness, sustainability and safety for patients;
Amendment 54 #
Motion for a resolution Recital L a (new) La. whereas there is still a considerable number of Member States where obstacles placed in the way of patients by health systems are significant; whereas this only deepens the fragmentation of access to services;
Amendment 55 #
Motion for a resolution Recital L a (new) L a. whereas the Eurobarometer Survey of May 2015 indicates that fewer than 20% of citizens feel well informed about their cross-border healthcare rights;
Amendment 56 #
Motion for a resolution Recital M M. whereas, according to a 2015 Eurobarometer survey, fewer than 20% of citizens were aware of their rights regarding cross-border healthcare; whereas the directive will only be effective if patients, healthcare professionals and other stakeholders are well informed about it;
Amendment 57 #
Motion for a resolution Recital M M. whereas the directive will only be effective if patients, healthcare professionals and other stakeholders are well informed about it and the rules governing it are easily available and easily understood;
Amendment 58 #
Motion for a resolution Recital M M. whereas the directive will only be effective if patients, carers, healthcare professionals and other stakeholders are well informed about it;
Amendment 59 #
Motion for a resolution Recital M M. whereas
Amendment 6 #
Motion for a resolution Recital A A. whereas affordable-to-all health systems in the EU are crucial for ensuring a high level of social protection, social cohesion and social justice;
Amendment 60 #
Motion for a resolution Recital N N. whereas patients and healthcare professionals are still encountering a large information gap regarding patients’ rights in general and in particular those under the directive;
Amendment 61 #
Motion for a resolution Recital N N. whereas patients, carers and healthcare professionals are still encountering a large information gap regarding patients’ rights under the directive;
Amendment 62 #
Motion for a resolution Recital N a (new) N a. whereas healthcare professionals cover highly sensitive issues of patients that require clear and easy understandable communication, a language barrier might impede the transfer of information between healthcare professionals and their patients;
Amendment 63 #
Motion for a resolution Recital N a (new) N a. whereas in terms of data, not all the Member States were able to supply data or information regarding the patient travelling abroad; whereas data collection is not always comparable from one Member State to another;
Amendment 64 #
Motion for a resolution Recital N a (new) N a. whereas there is considerable room for improvement in the reimbursement guidelines particularly with respect to upfront payment requirements, prescriptions and follow-up therapy and procedures;
Amendment 65 #
Motion for a resolution Recital O O. whereas there is considerable room for improvement and simplification in the reimbursement procedures in a number of Member States; whereas, at the same time, procedures should be strengthened to enable any cases of fraud to be detected;
Amendment 66 #
Motion for a resolution Recital O O. whereas there is considerable room for improvement in the reimbursement procedures in a number of Member States, including for orphan drugs and pharmaceutically compounded medicinal products;
Amendment 67 #
Motion for a resolution Recital Q Q. whereas there are a number of bilateral agreements between neighbouring Member States and regions that could serve as a basis for excellent best practices to further develop EU-wide cross-border healthcare, including exchange of information on potential essential medicines shortages;
Amendment 68 #
Motion for a resolution Recital Q a (new) Q a. whereas authorisation systems are intended to allow for Member State planning and protect patients from treatments raising serious and specific concerns relating to the quality or safety of the care;
Amendment 69 #
Motion for a resolution Recital Q a (new) Q a. whereas a growing number of citizens of the Union desire unimpaired access to and make use of preventive medical tests, scans and health checks available in other Member States;
Amendment 7 #
Motion for a resolution Recital A A. whereas health systems in
Amendment 70 #
Motion for a resolution Paragraph 1 1.
Amendment 71 #
Motion for a resolution Paragraph 2 2. Invites the Commission to proceed with its triennial evaluation reports on the operation of the directive and to submit them to Parliament and the Council accordingly; calls on the Commission furthermore to publish, on an annual basis, breakdowns of the benefits recognised and total amounts reimbursed by each Member State as cross-border healthcare provision;
Amendment 72 #
Motion for a resolution Paragraph 2 a (new) 2a. Calls on the Commission and the Member States to mount more comprehensive public information campaigns to ensure that all EU citizens are aware of their rights and obligations under this legislation;
Amendment 73 #
Motion for a resolution Paragraph 2 a (new) 2 a. Invites the Commission to adopt quality of life for the patient and patient care outcomes as a consideration in the evaluation of the cost-efficiency of the implementation of the directive;
Amendment 74 #
Motion for a resolution Paragraph 3 3. Reminds the Member States of their commitment to provide the Commission with assistance and all the requisite information at their disposal, for the purposes of carrying out its assessment and preparing the aforesaid reports; also reminds the Member States that they need to act in a committed manner, complying with the implementation deadlines laid down in the legislation;
Amendment 75 #
Motion for a resolution Paragraph 3 a (new) 3 a. Invites the Commission to establish guidelines for implementation, especially where Regulation 883/2004 on the coordination of social security systems and the Directive 2011/24/EU on the application of patient's rights in cross- border healthcare interact, and to ensure better coordination amongst all relevant stakeholders within the institutions;
Amendment 76 #
Motion for a resolution Paragraph 4 4. Stresses that the Member States should transpose the directive correctly in order to ensure the highest level of quality and secure easily accessible cross-border healthcare for patients and encourages development of access gates to the NCP in order to foster access to digital space for health insitutions;
Amendment 77 #
Motion for a resolution Paragraph 4 4. Stresses that the Member States should transpose the directive correctly and as soon as possible in order to ensure the highest level of quality and secure easily accessible cross-border healthcare for patients;
Amendment 78 #
Motion for a resolution Paragraph 4 4. Stresses that the Member States should transpose the directive correctly in order to ensure
Amendment 79 #
Motion for a resolution Paragraph 4 a (new) 4a. Calls on the Commission to harmonise the criteria governing access to the European Health Insurance Card, and the validity of the card, as well as the healthcare services covered; calls, furthermore, on the Member States to guarantee access to the European Health Insurance Card for all EU citizens, including temporary workers, self- employed persons and those in atypical employment relationships, as well as mobile jobseekers, without discrimination;
Amendment 8 #
Motion for a resolution Recital A A. whereas health systems in the EU are crucial for ensuring a high level of social protection, public health, social cohesion and social justice;
Amendment 80 #
Motion for a resolution Paragraph 4 a (new) 4 a. Recommends that the Commission develops step-by-step guidelines for the NCPs, in cooperation with relevant patient organisations, informing patients on how to use cross-border healthcare services, and creates a standardised template for all types of forms required for cross-border healthcare;
Amendment 81 #
Motion for a resolution Paragraph 4 a (new) 4 a. Underlines that digitalization could bring an added value to the implementation of the Directive, and e- health interoperability should be a priority to improve global patient records and continuity of care;
Amendment 82 #
Motion for a resolution Paragraph 4 b (new) 4b. Calls on the Commission to take the necessary steps, and calls on the Member States to introduce policies to boost the quality of their health services, and to ensure that coordination at EU level does not under any circumstances give rise to discrimination, nor place an excessive burden on national systems funded by the taxpayer;
Amendment 83 #
Motion for a resolution Paragraph 4 c (new) 4c. Calls on the Commission to consider expanding the scope of the directive to include vaccination programmes;
Amendment 84 #
Motion for a resolution Paragraph 4 d (new) 4d. Emphasises that cross-border healthcare coordination may be beneficial in areas in which there is a need for awareness-raising or action to facilitate citizens’ mobility, but not in order to encourage such mobility; in this respect, recognises that there is a role to be played in health technology assessment and rare diseases, and that improvements need to be made with regard to access to prescribed medicines and continuity of treatment prescribed by the Member State of affiliation;
Amendment 85 #
Motion for a resolution Paragraph 4 e (new) 4e. Calls on the Commission and the Member States to promote the development and harmonisation of the European Health Insurance Card as an essential tool with which to guarantee freedom of movement for EU citizens, as well as cross-border healthcare, points out that obstacles to its use must be removed, and therefore that an automatic reimbursement system needs to be introduced across the Member States;
Amendment 86 #
Motion for a resolution Paragraph 5 5.
Amendment 87 #
Motion for a resolution Paragraph 5 5. Expresses serious concern about the proposed reduction in funding for the health programme; reiterates its call for the health programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027), in order to implement the UN Sustainable Development Goals (SDGs) on public health, health systems and environment- related problems, and ensure an ambitious health policy with a focus on cross-border challenges, including, in particular, a considerable increase in common EU efforts in the prevention and treatment of pandemic diseases, the fight against cancer, the prevention of chronic and rare diseases including genetic diseases, combating anti-microbial resistance and ensuring easier access to cross-border healthcare;
Amendment 88 #
Motion for a resolution Paragraph 5 5. Expresses serious concern about the proposed reduction in funding for the health programme; reiterates its call for the health programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027), in order to implement the UN Sustainable Development Goals (SDGs) on public health, health systems and environment- related problems, and ensure an ambitious health policy with a focus on cross-border challenges, including, in particular, a considerable increase in common EU efforts in the fight against cancer, the prevention and management of chronic and rare diseases, including rare cancers, combating anti-microbial resistance and ensuring easier access to cross-border healthcare;
Amendment 89 #
Motion for a resolution Paragraph 5 5. Expresses serious concern about the proposed reduction in funding for the health programme; reiterates its call for the health programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027), in order to implement the UN Sustainable Development Goals (SDGs) on public health, health systems and environment- related problems, and ensure an ambitious health policy with a focus on cross-border challenges, including, in particular, a considerable increase in common EU efforts in the fight against cancer, the prevention and detection of chronic and rare diseases, combating anti-microbial resistance and ensuring easier access to cross-border healthcare;
Amendment 9 #
Motion for a resolution Recital A a (new) Aa. whereas cross-border healthcare, as regulated by Directive 2001/24/EU, is another healthcare option in the countries within the European Area to add to those already in place;
Amendment 90 #
Motion for a resolution Paragraph 5 5. Expresses serious concern about the proposed reduction in funding for the health programme; reiterates its call for the health programme to be restored as a robust stand-alone programme with increased funding in the next multiannual financial framework (MFF) (2021-2027), in order to implement the UN Sustainable Development Goals (SDGs) on public health, health systems and environment- related problems, and ensure an ambitious health policy with a focus on cross-border challenges, including
Amendment 91 #
Motion for a resolution Paragraph 5 a (new) 5 a. Stresses the importance of the European Social Fund and the European Regional Development Fund, including the Interreg Programme, in improving health services and in reducing health inequalities between regions and social groups across Member States; requests that structural and cohesion funds can also be used to improve and facilitate cross border healthcare in the next MFF;
Amendment 92 #
Motion for a resolution Paragraph 6 6. Notes that the reasons for low patient mobility are
Amendment 93 #
Motion for a resolution Paragraph 6 6. Notes that the reasons for low patient mobility are
Amendment 94 #
Motion for a resolution Paragraph 6 6. Notes that the reasons for low patient mobility are
Amendment 95 #
Motion for a resolution Paragraph 6 6. Notes that the reasons for low patient mobility are threefold: i) some Member States were quite late implementing the directive; ii) citizens’ awareness about their general rights to reimbursement is extremely low and this access to their rights has, moreover, been hampered by the heavy administrative burdens imposed, and iii) Member States have transposed the directive in ways that could be construed as limiting cross-border healthcare;
Amendment 96 #
Motion for a resolution Paragraph 6 6. Notes that the reasons for low patient mobility are t
Amendment 97 #
Motion for a resolution Paragraph 6 a (new) 6a. Calls on the Commission and the Member States to revise Article 7 of Directive 2011/24/EU so as to guarantee free movement for EU citizens and their families, without discrimination;
Amendment 98 #
Motion for a resolution Paragraph 6 a (new) 6 a. Highlights the importance to collect and have available the data for patients travelling abroad for treatment, and calls upon the Commission to address this matter through a European Record for patients;
Amendment 99 #
Motion for a resolution Paragraph 6 a (new) 6a. Draws the Commission’s attention to the fact that advance payments for patients receiving cross-border healthcare can form a social barrier and should be avoided where possible;
source: 631.903
|
History
(these mark the time of scraping, not the official date of the change)
2023-08-03Show (7) Changes | Timetravel
| committees/0/associated |
Old
TrueNew
|
| committees/1 |
Old
New
|
| committees/2 |
Old
New
|
| docs/0/docs/0/url |
https://www.europarl.europa.eu/doceo/document/ENVI-PR-628580_EN.html
|
| docs/1/docs/0/url |
https://www.europarl.europa.eu/doceo/document/IMCO-AD-623966_EN.html
|
| docs/2/docs/0/url |
https://www.europarl.europa.eu/doceo/document/ENVI-AM-631903_EN.html
|
| events/5/docs |
|
2021-12-18Show (12) Changes | Timetravel
| docs/0/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE628.580
|
| docs/1/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE623.966&secondRef=02
|
| docs/2/docs/0/url |
http://www.europarl.europa.eu/sides/getDoc.do?type=COMPARL&mode=XML&language=EN&reference=PE631.903
|
| events/0/type |
Old
Committee referral announced in Parliament, 1st reading/single readingNew
Committee referral announced in Parliament |
| events/2/type |
Old
Vote in committee, 1st reading/single readingNew
Vote in committee |
| events/3 |
|
| events/3 |
|
| events/5/docs |
|
| events/6 |
|
| events/6 |
|
| procedure/Modified legal basis |
Rules of Procedure EP 159
|
| procedure/Other legal basis |
Rules of Procedure EP 159
|
2020-01-19Show (3) Changes | Timetravel
| docs/3/body |
EC
|
| events/3/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=REPORT&mode=XML&reference=A8-2019-0046&language=ENNew
http://www.europarl.europa.eu/doceo/document/A-8-2019-0046_EN.html |
| events/6/docs/0/url |
Old
http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P8-TA-2019-0083New
http://www.europarl.europa.eu/doceo/document/TA-8-2019-0083_EN.html |
2019-09-04Show (6) Changes | Timetravel
| committees/0 |
|
| committees/0 |
|
| committees/2 |
|
| committees/2 |
|
| docs/3 |
|
| events/4 |
|
2019-07-12Show (2) Changes | Timetravel
| committees/0 |
|
| committees/0 |
|
2019-07-06Show (20) Changes | Timetravel
| activities |
|
| commission |
|
| committees/0 |
|
| committees/0 |
|
| committees/1 |
|
| committees/1 |
|
| committees/2 |
|
| committees/2 |
|
| docs |
|
| events |
|
| links |
|
| other |
|
| procedure/Modified legal basis |
Rules of Procedure EP 159
|
| procedure/dossier_of_the_committee |
Old
ENVI/8/12701New
|
| procedure/legal_basis/0 |
Rules of Procedure EP 54
|
| procedure/legal_basis/0 |
Rules of Procedure EP 52
|
| procedure/stage_reached |
Old
Awaiting committee decisionNew
Procedure completed |
| procedure/subject |
Old
New
|
| procedure/subtype |
Old
ImplementationNew
|
| procedure/summary |
|
2018-09-12Show (1) Changes | Timetravel
| activities/1 |
|
2018-06-22Show (1) Changes | Timetravel
| procedure/legal_basis/0 |
Old
Rules of Procedure EP 052New
Rules of Procedure EP 52 |
2018-06-19Show (1) Changes | Timetravel
| other/0 |
|
2018-06-16Show (5) Changes
| activities |
|
| committees |
|
| links |
|
| other |
|
| procedure |
|